John J. Lee | Medical Services
Specialties
Programs & Services
- Allergy and Asthma Program
- Eosinophilic Gastrointestinal Disease Program
- Immunology
- Immunology Program
Languages
- English
John J. Lee | Education
Undergraduate School
Yale University
1995, New Haven, CT
Medical School
New York University School of Medicine
2000, New York, NY
Internship
Children's Hospital of Philadelphia
2001, Philadelphia, PA
Residency
Children's Hospital of New York, Columbia Presbyterian Medical Center
2003, New York, NY
Fellowship
Allergy/Immunology
Boston Children's Hospital
2008, Boston, MA
John J. Lee | Certifications
- American Board of Allergy & Immunology (General)
- American Board of Pediatrics (Pulmonology)
John J. Lee | Publications
Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2014 Sep; 59(3):317-20. View Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children. Abstract
Creating a new community of support for students with food allergies. NASN Sch Nurse. 2012 Sep; 27(5):260-6. View Creating a new community of support for students with food allergies. Abstract
The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. J Allergy Clin Immunol. 2010 Dec; 126(6):1234-41.e2. View The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. Abstract
The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Blood. 2009 Sep 10; 114(11):2254-62. View The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Abstract
Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells. J Allergy Clin Immunol. 2009 Jun; 123(6):1277-86.e5. View Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells. Abstract
Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Curr Opin Allergy Clin Immunol. 2008 Dec; 8(6):520-6. View Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Abstract
Children's Hospital Profile. View Children's Hospital Profile Abstract